The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

A study looked at the impact on children who are exposed to glucocorticoids - synthetic versions of naturally occurring ...